Plain-English translation of NCT04965545 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Wilson disease is a rare inherited condition where the body cannot properly manage copper, leading to serious health problems. This study is looking at blood tests and eye findings (called Kayser-Fleischer rings) to figure out the best and quickest ways to diagnose Wilson disease in patients. By studying these diagnostic methods, researchers hope to help doctors identify and treat the condition earlier.
Many patients with Wilson disease have different symptoms and lab results, which can make it hard for doctors to diagnose the condition quickly and correctly. This study aims to identify which blood tests and physical signs are most reliable for catching Wilson disease early.
You likely qualify if…
You likely don't qualify if…
As a participant, you would be part of a group of up to 1,000 patients with Wilson disease. The study involves having blood tests and possibly eye examinations to look for Kayser-Fleischer rings (copper deposits in the cornea). Researchers will collect information about your medical history and test results to better understand patterns in how Wilson disease is diagnosed. You would need to be willing to attend follow-up visits as part of the study.
AI-generated summary from trial data · Jul 11, 2026 · Not medical advice
China
Enrollment target
~1,000 participants
Started
January 2004
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
6 Years – 65 Years
Last updated on clinicaltrials.gov in July 2021.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yi Dong, Ph.D.
Second Affiliated Hospital, Zhejiang University School of Medicine
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.